Financhill
Sell
16

AWH Quote, Financials, Valuation and Earnings

Last price:
$0.12
Seasonality move :
6.35%
Day range:
$0.12 - $0.13
52-week range:
$0.12 - $3.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
--
Volume:
3.1M
Avg. volume:
8M
1-year change:
-96.42%
Market cap:
$2.1M
Revenue:
$9.2M
EPS (TTM):
-$1.20

Earnings Data

Next earnings date for AWH
Mar 28
2025
Most recent earnings per share
-$0.23
Beat by $0.05
(Nov 14/2024)
Consensus Estimate
-$0.28
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AWH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $5M -- -- -$0.15 --
03/28/2025 Q4 $3M -- -- -$0.22 --
11/14/2024 Q3 $2.7M $2.3M -$0.23 -$0.28 $0.05
08/12/2024 Q2 $2.6M $2.4M -$0.28 -$0.33 $0.05
05/15/2024 Q1 $2.6M $2.2M -$0.39 -$0.32 -$0.07
03/28/2024 Q4 $2.6M $2.1M -$0.30 -$0.41 $0.11
11/13/2023 Q3 -- -- -$0.48 -$0.40 -$0.08
08/14/2023 Q2 -- -- -$0.28 -$0.44 $0.16
05/11/2023 Q1 -- -- -$0.79 -$0.60 -$0.19
03/22/2023 Q4 -- -- -$0.60 -$1.05 $0.45
11/10/2022 Q3 -- -- -$1.00 -- --
08/10/2022 Q2 -- -- -$1.10 -- --
05/11/2022 Q1 -- -- -$1.24 -- --
03/23/2022 Q4 -- -- -$1.27 -- --
11/10/2021 Q3 -- -- -$1.35 -- --
08/12/2021 Q2 -- -- -$0.90 -- --
05/13/2021 Q1 -- -- -$0.75 -- --
03/25/2021 Q4 -- -- -$8.70 -- --
11/12/2020 Q3 -- -- -$0.60 -- --
08/13/2020 Q2 -- -- -$0.60 -- --
05/14/2020 Q1 -- -- -$0.60 -- --
03/26/2020 Q4 -- -- -$0.45 -- --
11/12/2019 Q3 -- -- -$0.60 -- --
08/08/2019 Q2 -- -- -$0.90 -- --
05/14/2019 Q1 -- -- -$0.75 -- --
03/28/2019 Q4 -- -- -$0.60 -- --
11/08/2018 Q3 -- -- -$0.60 -- --
08/09/2018 Q2 -- -- -$0.60 -- --
05/14/2018 Q1 -- -- -$0.75 -- --
03/13/2018 Q4 -- -- -$0.75 -- --
11/08/2017 Q3 -- -- -$0.90 -- --
08/08/2017 Q2 -- -- -$0.60 -- --
05/11/2017 Q1 -- -- -$0.75 -- --
03/29/2017 Q4 -- -- -$0.75 -- --
11/10/2016 Q3 -- -- -$1.05 -- --
08/10/2016 Q2 -- -- -$1.05 -- --
05/16/2016 Q1 -- -- -$1.35 -- --
03/30/2016 Q4 -- -- -$1.50 -- --
11/12/2015 Q3 -- -- -$1.50 -- --
08/13/2015 Q2 -- -- -$1.65 -- --
05/11/2015 Q1 -- -- -$1.50 -- --

Aspira Womens Health Earnings Questions

  • How Much did Aspira Womens Health Generate in Revenue Last Quarter?

    Aspira Womens Health reported $2.3M worth of top line sales in its most recent quarter.

  • Did Aspira Womens Health Beat Earnings Last Quarter?

    Aspira Womens Health announced earnings per share of -$0.23 which represents a beat of analyst forecast a -$0.28 per share.

  • Is Aspira Womens Health Profitable?

    Aspira Womens Health reported $1.4M that represents $0.09 per share over the last quarter.

  • What is the Analyst Consensus for Aspira Womens Health EPS Next Year?

    Aspira Womens Health's earnings are forecast to decrease from -$1.81 per share to -$1.20 per share next year representing a decrease of -33.7%.

  • When is Aspira Womens Health's Earnings Date?

    Aspira Womens Health's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock